LIC sells 2% shares in Sun Pharma, stake now at 3.012%
The sale happened in the ordinary course of transaction, according to the insurer.
Stay updated with breaking news from Dr Reddys. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The sale happened in the ordinary course of transaction, according to the insurer.
Private equity firm Bain Capital has approached Indian pharmaceutical company Dr Reddy's Laboratories (DRL) to explore a joint bid for the promoters of Cipla, the Hamied family. DRL is evaluating the opportunity and countering an offer from Torrent Pharma, another Indian investor. If DRL decides to participate, the combined entity would become the leading Indian-origin pharma major at home and in the US and emerging markets.
Dr. Reddy's Laboratories, incorporated in the year 1984, is a Large Cap company (having a market cap of Rs 97945.46 Crore) operating in Pharmaceuticals sector.
India News: HYDERABAD: Pharma major Reddy’s Laboratories Ltd on Thursday announced its foray into the Indian child nutrition space with the rollout of its immunit.
The Hyderabad-based company's consolidated profit rose to Rs 959 crore in the three months ended 31 March, compared with Rs 875 crore a year earlier, , dr reddys